Compound Detail
CHEMBL1465
PHENPROCOUMON 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1465 |
| Name | PHENPROCOUMON |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | DQDAYGNAKTZFIW-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
4
Targets
11
Activities
2
Assay Types
0
PK Parameters
20
Publications
12
Known Names
4
Indications
1
Mechanisms
Molecular Properties
280.3
MW (Da)
4.04
ALogP
3
HBA
1
HBD
50.4
PSA (Ų)
0.74
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1957 |
| Availability | Discontinued |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor | INHIBITOR | Vitamin K epoxide reductase complex subunit 1 | ✓ | ✓ |
Indications
Thrombosis Venous Thrombosis Venous Thrombosis Melanoma
ATC Classification
B01AA04
phenprocoumon
Level 1: BLOOD AND BLOOD FORMING ORGANS
Level 2: ANTITHROMBOTIC AGENTS
Activity Summary
Ki 7 meas. best 6.7
IC50 4 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 CHEMBL4105870 | Ki | 6.7 | 6.7 | 200.0 | 1 |
| Human immunodeficiency virus type 1 protease CHEMBL243 | Ki | 6.1 | 6.025 | 800.0 | 4 |
| Human immunodeficiency virus type 1 protease CHEMBL243 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Human immunodeficiency virus CHEMBL613758 | IC50 | 4.0 | 4.0 | 100000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 28254487 | 10.1016/j.bmcl.2017.02.017 | Rattus norvegicus | 2 |
| 28254487 | 10.1016/j.bmcl.2017.02.017 | Liver | 2 |
| 16610785 | 10.1021/jm0508538 | Cytochrome P450 2D6 | 1 |
| 37393791 | 10.1016/j.ejmech.2023.115586 | Human immunodeficiency virus type 1 protease | 1 |
| 20020916 | 10.1080/15376510701857262 | Phospholipidosis | 1 |
| 17275317 | 10.1016/j.bmc.2007.01.014 | Unchecked | 1 |
| 7381857 | 10.1021/jm00179a017 | No relevant target | 1 |
| 15923115 | 10.1016/j.bmcl.2005.04.057 | Human immunodeficiency virus type 1 protease | 1 |
| 7932546 | 10.1021/jm00046a002 | ADMET | 1 |
| 7932546 | 10.1021/jm00046a002 | Human immunodeficiency virus type 1 protease | 1 |
| 8831779 | 10.1021/jm960296c | Human immunodeficiency virus type 1 protease | 1 |
| 9089336 | 10.1021/jm960441m | Human immunodeficiency virus type 1 protease | 1 |
| 8893827 | 10.1021/jm960541s | Human immunodeficiency virus type 1 protease | 1 |
| 7381857 | 10.1021/jm00179a017 | Cavia porcellus | 1 |
| 7381857 | 10.1021/jm00179a017 | Albumin | 1 |
Data from ChEMBL 36 via Core Engine